Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2463829019 | Carbidopa + levodopa 50mg/200mg m/r tablet (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2470308015 | Carbidopa + levodopa 50mg/200mg m/r tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2576154015 | Co-careldopa 50mg/200mg m/r tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3401441000052115 | karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Is a | Product containing levodopa (medicinal product) | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Is a | Product containing carbidopa (medicinal product) | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Has active ingredient | Levodopa (substance) | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Has active ingredient | Carbidopa | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Is a | Product containing carbidopa and levodopa (medicinal product) | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Has manufactured dose form | Modified-release oral tablet (dose form) | false | Inferred relationship | Some | ||
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Is a | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Co-careldopa 50mg/200mg m/r tablet | Is a | False | karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR